Where is ReCode headquartered?

ReCode is located in Menlo Park, CA.

Who invested in ReCode?

ReCode has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for ReCode?

ReCode closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

recodetx.com

ReCode

ReCode is a California-based genetic medicines firm that researches and develops novel therapeutics for the treatment of cancer, CNS and cystic fibrosis.

Business Model:

Revenue: $6M

Employees: 51-200

Geographic Data

Address: 1455 Adams Drive

City: Menlo Park

State: CA

Zip: 94025

Country: US

Financial Info

Stage:

series b

Raised Last:

$120M

Raised Total:

$297M

Social

Twitter

Crunchbase

Metrics

1,532,712Website Global Rank

16,559Website Monthly Traffic

Twitter Followers

Description

ReCode is a California-based genetic medicines firm that researches and develops novel therapeutics for the treatment of cancer, CNS and cystic fibrosis.

Contact Phone:
+14085851700

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2019	Seed Round		$2M
10/2021	Series B		$80M	EcoR1 Capital Sanofi Ventures Tekla Capital Management LLC NS Investment OrbiMed Vida Ventures MPM Capital Colt Ventures Osage University Partners
6/2022	Series B		$0	Amgen Ventures Leaps by Bayer Matrix Capital Management Pfizer Venture Investments Sanofi Ventures Amgen Ventures Leaps by Bayer Matrix Capital Management Pfizer Venture Investments Sanofi Ventures
3/2020	Series A		$0	Colt Ventures OrbiMed Hunt Technology Ventures MPM Capital OUP (Osage University Partners) Vida Ventures Colt Ventures OrbiMed Hunt Technology Ventures MPM Capital OUP (Osage University Partners) Vida Ventures
1/2023	Venture Round	1	$10M	Cystic Fibrosis Foundation Cystic Fibrosis Foundation
10/2021	Series B		$0	Colt Ventures EcoR1 Capital Hunt Technology Ventures MPM Capital NS Investment OrbiMed OUP (Osage University Partners) Pfizer Venture Investments Sanofi Ventures Superstring Capital Tekla Capital Management Vida Ventures Colt Ventures EcoR1 Capital Hunt Technology Ventures MPM Capital NS Investment OrbiMed OUP (Osage University Partners) Pfizer Venture Investments Sanofi Ventures Superstring Capital Tekla Capital Management Vida Ventures
1/2023	Equity		$15M	Cystic Fibrosis Foundation
12/2016	Seed		$2M
6/2022	Series B	5	$120M	Leaps by Bayer EcoR1 Capital Sanofi Ventures Amgen Ventures Leaps by Bayer Matrix Capital Management Pfizer Venture Investments Sanofi Ventures
3/2020	Series A	6	$80M	OrbiMed Advisors LLC Colt Ventures LP MPM Capital Vida Ventures LLC Osage University Partners Colt Ventures OrbiMed
10/2021	Series B	12	$160M	Colt Ventures EcoR1 Capital Hunt Technology Ventures MPM Capital NS Investment OrbiMed OUP (Osage University Partners) Pfizer Venture Investments Sanofi Ventures Superstring Capital Tekla Capital Management Vida Ventures Colt Ventures EcoR1 Capital Hunt Technology Ventures MPM Capital NS Investment OrbiMed OUP (Osage University Partners) Pfizer Venture Investments Sanofi Ventures Superstring Capital Tekla Capital Management Vida Ventures

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details